Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 33, 2019 - Issue 19
210
Views
4
CrossRef citations to date
0
Altmetric
Short Communication

A new abietane diterpenoid glycoside from ajuga ovalifolia var. calantha

, , , , , , , , & show all
Pages 2856-2859 | Received 10 May 2018, Accepted 10 Jul 2018, Published online: 13 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yunjung Lee, Hye Mi Kim, Ji Hoon Kim, Ju-Hee Lee, Kai Xuan Zhang, En Mei Gao, Je-Seung Jeon, Ahmed Shah Syed, Rak Ho Son, Jae-Yong Kim & Chul Young Kim. (2023) Chemical constituents of the Ajuga multiflora bunge and their protective effects on dexamethasone-induced muscle atrophy in C2C12 myotubes. Natural Product Research 37:12, pages 1978-1985.
Read now

Articles from other publishers (3)

Hongling Yan, Miao Jiang, Fujin Yang, Xueyong Tang, Mao Lin, Chunyan Zhou, Yuzhu Tan & Deming Liu. (2022) Ajuforrestin A, an Abietane Diterpenoid from Ajuga ovalifolia var. calanthe, Induces A549 Cell Apoptosis by Targeting SHP2. Molecules 27:17, pages 5469.
Crossref
Haijuan Wang, Xifeng Teng, Yuting Zhang, Qiong Gu & Lin He. (2020) Diterpenoids from the Whole Plants of Ajuga nipponensis and Their Inhibition of RANKL‐Induced Osteoclastogenesis . Chemistry & Biodiversity 18:1.
Crossref
De-ming Liu, Zhi-Xing Cao, Hong-ling Yan, Wen Li, Fan Yang, Wen-Ji Zhao, Qing-chun Diao & Yu-zhu Tan. (2020) A new abietane diterpenoid from Ajuga ovalifolia var. calantha induces human lung epithelial A549 cell apoptosis by inhibiting SHP2. Fitoterapia 141, pages 104484.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.